COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies

•The pandemic COVID-19 requires alternative methods and thinking to keep healthcare professionals and patients safe.•In COVID-19 hot spots, oral therapies may be viable alternatives to intravenous therapies for treatment of ovarian cancer.•Minimizing patient visits to hospitals and cancer clinics ma...

Full description

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2020-07, Vol.158 (1), p.34-36
Main Authors: Monk, Bradley J., Coleman, Robert L., Moore, Kathleen N., Herzog, Thomas J., Secord, Angeles Alvarez, Matulonis, Ursula A., Slomovitz, Brian M., Guntupalli, Saketh R., O'Malley, David M.
Format: Article
Language:English
Subjects:
Administration, Oral
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Betacoronavirus - isolation & purification
Coronavirus Infections - epidemiology
Coronavirus Infections - prevention & control
Coronavirus Infections - virology
COVID-19
Female
Humans
Infusions, Intravenous
Oral
Organoplatinum Compounds - administration & dosage
Ovarian cancer
Ovarian Neoplasms - drug therapy
Ovarian Neoplasms - virology
Pandemics - prevention & control
Pneumonia, Viral - epidemiology
Pneumonia, Viral - prevention & control
Pneumonia, Viral - virology
Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage
SARS-CoV-2
Targeted therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•The pandemic COVID-19 requires alternative methods and thinking to keep healthcare professionals and patients safe.•In COVID-19 hot spots, oral therapies may be viable alternatives to intravenous therapies for treatment of ovarian cancer.•Minimizing patient visits to hospitals and cancer clinics may help mitigate the spread of SARS-CoV-2.
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2020.04.703